A study published recently in the journal Cells details the critical role mitochondrial cannabinoid receptors play in maintaining skeletal muscle energy production and contractile performance.
Researchers from the University of Szeged and the University of Debrecen investigated mitochondrial CB1 receptors (mtCB1Rs), a distinct population of cannabinoid receptors located within skeletal muscle mitochondria. Using a novel mouse model with targeted deletion of mtCB1Rs, the team uncovered striking impacts on muscle physiology.
Although the knockout mice showed no changes in motor function, grip strength, or coordination, detailed muscle testing revealed reduced force generation in both fast-twitch and slow-twitch muscles. Interestingly, hypertrophy was observed in certain muscle types, suggesting a compensatory response to reduced contractile quality.
Electron microscopy revealed abnormal mitochondrial structures, while advanced respirometry confirmed diminished oxidative phosphorylation and electron transport capacity. Knockout muscle fibers also displayed faster dissipation of mitochondrial membrane potential and elevated resting calcium levels, both indicators of impaired energy regulation.
Taken together, the findings demonstrate that mtCB1Rs are essential for mitochondrial health and efficient muscle function. The researchers conclude that the endocannabinoid system directly influences skeletal muscle performance, offering potential therapeutic pathways for addressing muscle-related disorders and age-associated decline. Given that cannabis directly stimulates the cannabinoid receptors, researchers say the study’s findings could indicate that cannabis could improve skeletal health.





